Navigation Links
RRD Announces Move to New Corporate Headquarters
Date:9/9/2010

ROCKVILLE, Md., Sept. 9 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that they have moved to expanded offices this month.  The new office space, located at 7361 Calhoun Place, Rockville, MD, recently completed build-out and more than doubles RRD's business footprint to 13,000 sq ft.

"This move is symbolic of the growth and success RRD has achieved in the last year," said Scott Tarrant, Chief Business Officer, RRD International. "Our model has proven time and again to be more efficient and successful than traditional methods, and the market's increasing demand for RRD services necessitated finding a new space to accommodate our growing needs."

RRD International delivers tactical, regulatory-driven product development support to companies and investors in the life sciences industry. Leveraging its in-house strategic and operational expertise, the Company helps clients better plan, manage and execute product development. Having successfully completed more than 80 product development engagements with a wide range of organizations, RRD International's fully integrated development team works to enable rapid proof of concept, reduce costs, and accelerate value creation.

"Times of growth and change are always exciting," added Chuck Finn, President and CEO, RRD International.  "We're thrilled to have found a place that lets us remain in Rockville and better serve our clients and partners."

About RRD International

Founded in 2002, RRD is a strategy-driven product development company. The Company's development model enables rapid proof of concept for biotech and pharmaceutical clients to accelerate value inflection points; reduce costs; and mitigate development as well as execution risk. RRD offers two distinct types of client engagements: TacDev® and DevCo®. The TacDev® model adds development bandwidth and expertise for defined products in companies with minimal infrastructure. The DevCo® model creates external product development companies where investment is in asset optimization rather than traditional infrastructure. For more information visit: www.rrdintl.com. RRD International: Accelerating the Right Development; Creating Lasting Value.


'/>"/>
SOURCE RRD International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Huifeng Bio-Pharmaceutical Technology, Inc. Announces the Acquisition of Shangqiu Kexin Rutin Processing Ltd.
2. Martek Announces Third Quarter FY 2010 Financial Results
3. ReproCELL Announces New Line of Services in Neuronal Research Using Human iPS Cells
4. Medisafe 1 Technologies Announces 1-5 Stock Dividend
5. DGP Group Rebrands as Intelsius and Announces Launch of New, Innovative Packaging System - Orcatherm™
6. EUSA Pharma Announces the Appointment of Stephen A. Stamp to its Board of Directors
7. Biodel Announces Name Change for Lead Product Candidate
8. Enerkem Announces Construction Start of Worlds First Municipal Waste-to-Biofuels Facility in Edmonton, Alberta
9. MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
10. Glenmark Announces the Discovery of a Novel Chemical Entity GRC 17536, a TRPA1 Receptor Antagonist, a Potential First-in-Class Molecule Globally
11. ThermoGenesis Announces Sale of BioArchive Systems In Asia as Company Increases Presence In Key Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... cellulose nanocrystals and cellulose nanofibrils. The composition claims are not limited to ... claims directed to combination with polymers, carbon fibers, graphene, and other materials. ...
(Date:12/5/2016)... Dec. 5, 2016  Renova™ Therapeutics, a biotechnology ... failure and other chronic diseases, announced that ... as Chief Financial Officer (CFO), effective today. ... years of experience in financial management for a ... software companies. Most recently, Ms. Bovenizer was the ...
(Date:12/5/2016)... The U.S. Biotechnology industry is ... of revenue and some $890 billion of total market ... biopharmaceuticals, and this figure is expected to exceed $220 ... these four equities for assessment: Northwest Biotherapeutics Inc. (NASDAQ: ... ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... ... December 02, 2016 , ... In anticipation of ... lumbar disc production, company President, Jake Lubinski will be traveling to Switzerland from ... disc in Bern, Lucerne, and Zurich to discuss the benefits of a viscoelastic ...
Breaking Biology Technology:
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. ... has priced an offering of €500.0 million principal amount of ... principal amount of its 2.425% senior unsecured notes due 2026. ... to occur on December 13, 2016, subject to the satisfaction of ... annual basis. The Company intends ...
(Date:12/6/2016)... , Dec. 6, 2016 Valencell , the ... it has seen a third consecutive year of triple ... technology in 2016 with a 360 percent increase in ... This increase was driven by sales of its wrist ... interest in its technology for hearables for fitness and ...
(Date:12/6/2016)... Dec. 6, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... today a five (5) year funding commitment by ... expand the rehabilitation and reentry support to more ... Established in 2004, the Prison Entrepreneurship Program (PEP) ...
Breaking Biology News(10 mins):